Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
Author Information
Author(s): Jessica Yeates, Mohsin Rashid
Primary Institution: Dalhousie University, IWK Health Centre
Hypothesis
Can infliximab effectively treat chronic refractory pouchitis in adolescents?
Conclusion
Infliximab is a safe and effective therapy for refractory pouchitis in adolescents, maintaining long-term remission.
Supporting Evidence
- The patient had severe ulcerative pancolitis and underwent colectomy and IPAA.
- After failing multiple treatments, infliximab was administered and resulted in immediate symptom relief.
- The patient remained in complete remission for 36 months after starting infliximab.
Takeaway
This study shows that a medicine called infliximab can help kids with a tough tummy problem called pouchitis feel better and stay healthy for a long time.
Methodology
Case report of an adolescent treated with infliximab for chronic refractory pouchitis after colectomy and IPAA.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
An adolescent female with a history of severe ulcerative colitis and pouchitis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website